newsfilter
← Latest News
GlobeNewswire·

MoonLake Reports Third Quarter 2026 Financial Results and Provides a Business Update

Biologics License Application for sonelokimab submitted to the U.S. Food and Drug Administration for the treatment of adults and adolescents with moderate-to-severe hidradenitis suppurativa, marking an important step